Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Q&A
Pharma & Biotech
The Broadening Use of siRNA in the Clinic: DeciBio's Q&A with June Park, CEO of siRNAgen Therapeutics
Read our lastest Q&A with June Park, CEO of siRNAgen, a novel RNAi platform spun out of Korea-based Bioneer
November 21, 2022
DeciBio Q&A
Pharma & Biotech
The Broadening Use of siRNA in the Clinic: DeciBio's Q&A with June Park, CEO of siRNAgen Therapeutics
Read our lastest Q&A with June Park, CEO of siRNAgen, a novel RNAi platform spun out of Korea-based Bioneer
November 21, 2022
Next-Generation Therapeutics
DeciBio Q&A
Pharma & Biotech
AI’s Impact on the Clinical Pathology Lab: DeciBio's Q&A with Paige’s CEO Andy Moye
Check out our latest Q&A with Andy Moye of Paige, a company using a cloud-based AI Platform to help drive drug discovery and treatment for cancer.
November 9, 2022
DeciBio Q&A
Pharma & Biotech
AI’s Impact on the Clinical Pathology Lab: DeciBio's Q&A with Paige’s CEO Andy Moye
Check out our latest Q&A with Andy Moye of Paige, a company using a cloud-based AI Platform to help drive drug discovery and treatment for cancer.
November 9, 2022
Digital Pathology
AI / Machine Learning
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | October Roundup
October brought numerous updates in the regulatory world for Liquid Biopsy (LBx), with additional developments in partnerships, clinical findings, and fundraising.
November 8, 2022
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | October Roundup
October brought numerous updates in the regulatory world for Liquid Biopsy (LBx), with additional developments in partnerships, clinical findings, and fundraising.
November 8, 2022
Liquid Biopsy
DeciBio Q&A
Pharma & Biotech
Automated Digital Health Intervention: DeciBio’s Q&A with Dr. Yossi Bahagon of Sweetch
In our latest Q&A, our experts spoke with Dr. Yossi Bahagon of Sweetch, an AI digital health platform.
November 4, 2022
DeciBio Q&A
Pharma & Biotech
Automated Digital Health Intervention: DeciBio’s Q&A with Dr. Yossi Bahagon of Sweetch
In our latest Q&A, our experts spoke with Dr. Yossi Bahagon of Sweetch, an AI digital health platform.
November 4, 2022
Digital Health
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | October Roundup
Check out our newsletter to heard about the numerous exciting updates ranging from new company creation (Pheon Therapeutics) to major partnerships.
November 2, 2022
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | October Roundup
Check out our newsletter to heard about the numerous exciting updates ranging from new company creation (Pheon Therapeutics) to major partnerships.
November 2, 2022
Next-Generation Therapeutics
Blog Article
Clinical Diagnostics
Pathology Visions 2022 - DeciBio Highlights: Growing Traction for Digital Pathology
Our experts highlight some of the key Digital Pathology trends and themes from the 2022 Pathology Visions conference.
October 31, 2022
Blog Article
Clinical Diagnostics
Pathology Visions 2022 - DeciBio Highlights: Growing Traction for Digital Pathology
Our experts highlight some of the key Digital Pathology trends and themes from the 2022 Pathology Visions conference.
October 31, 2022
Digital Pathology
Precision Medicine
Real-world Data
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved